S, L. A., RM, v. S., MD, A., M, L., MA, v. d. A., CAR, L., . . . WJ, v. D. (2026). Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 36(7), 104500. https://doi.org/10.1016/j.ijgc.2026.104500
Chicago Style (17th ed.) CitationS, Lot Aronson, van Stein RM, Algera MD, Lopez-Yurda M, van der Aa MA, Lok CAR, de Hingh IHJT, Sonke GS, and van Driel WJ. "Real-world Use and Outcomes of Hyperthermic Intra-peritoneal Chemotherapy for Stage III Ovarian Cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 36, no. 7 (2026): 104500. https://doi.org/10.1016/j.ijgc.2026.104500.
MLA (9th ed.) CitationS, Lot Aronson, et al. "Real-world Use and Outcomes of Hyperthermic Intra-peritoneal Chemotherapy for Stage III Ovarian Cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 36, no. 7, 2026, p. 104500, https://doi.org/10.1016/j.ijgc.2026.104500.
